Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCCG-ALL-2015 multicenter trial in pediatric acute lymphoblastic leukemia
ChiCTR-IPR-14005706Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vincristine, dexamethasone, methotrexate, imatinib and dasatinib in acute lymphoblastic leukemia (ALL) and Philadelphia-chromosome positive acute lymphoblastic leukemia (6 arms), sponsored by Shanghai Children's Medical Center. Primary endpoints: Bone marrow morphology, Bone marrow minimal residual disease and 22 more. Started Jan 2015; status: recruiting.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)Philadelphia-chromosome positive acute lymphoblastic leukemia
Beyond the preview
Go deeper on ChiCTR-IPR-14005706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005706.